Sickle red cell adhesion: Many issues and some answers

Transfusion Clinique et Biologique

Volumn 15, Issue 1-2, 2008, Pages 51-55

  Kaul, D K ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adhesion; Adhesion molecules; Endothelium; Sickle red cell deformability; Vaso occlusion

Indexed keywords

CELL ADHESION MOLECULE; VITRONECTIN RECEPTOR;

ARTICLE; BLOOD VESSEL OCCLUSION; CELL INTERACTION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ERYTHROCYTE ADHESIVENESS; HUMAN; MEDICAL RESEARCH; PATHOPHYSIOLOGY; SICKLE CELL; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; CELL ADHESION; ERYTHROCYTES; HUMANS; INTEGRIN ALPHAVBETA3;

EID: 45049085089     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2008.03.012     Document Type: Article

References (42)

1. Hoover R., Rubin R., Wise G., and Warren R. Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures. Blood 54 4 (1979) 872-876
2. Hebbel R.P., Yamada O., Moldow C.F., Jacob H.S., White J.G., and Eaton J.W. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest 65 1 (1980) 154-160
3. Hebbel R.P., Moldow C.F., and Steinberg M.H. Modulation of erythrocyte-endothelial interactions and the vasocclusive severity of sickling disorders. Blood 58 5 (1981) 947-952
4. Fabry M.E., and Nagel R.L. Heterogeneity of red cells in the sickler: a characteristic with practical clinical and pathophysiological implications. Blood Cells 8 1 (1982) 9-15
5. Kaul D.K., Fabry M.E., Windisch P., Baez S., and Nagel R.L. Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics. J Clin Invest 72 1 (1983) 22-31
6. Billett H.H., Kim K., Fabry M.E., and Nagel R.L. The percentage of dense red cells does not predict incidence of sickle cell painful crisis. Blood 68 1 (1986) 301-303
7. Ballas S.K., Larner J., Smith E.D., Surrey S., Schwartz E., and Rappaport E.F. Rheologic predictors of the severity of the painful sickle cell crisis. Blood 72 4 (1988) 1216-1223
8. Kaul D.K., Fabry M.E., and Nagel R.L. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci USA 86 9 (1989) 3356-3360
9. Kaul D.K., Fabry M.E., and Nagel R.L. Erythrocytic and vascular factors influencing the microcirculatory behavior of blood in sickle cell anemia. Ann N Y Acad Sci 565 (1989) 316-326
10. Barabino G.A., McIntire L.V., Eskin S.G., Sears D.A., and Udden M. Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood 70 1 (1987) 152-157
11. Mohandas N., and Evans E. Sickle erythrocyte adherence to vascular endothelium. Morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins. J Clin Invest 76 4 (1985) 1605-1612
12. Fabry M.E., Fine E., Rajanayagam V., et al. Demonstration of endothelial adhesion of sickle cells in vivo: a distinct role for deformable sickle cell discocytes. Blood 79 6 (1992) 1602-1611
13. Kaul D.K., Fabry M.E., Costantini F., Rubin E.M., and Nagel R.L. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest 96 6 (1995) 2845-2853
14. Kaul D.K., Kollander R., Mahaseth H., et al. Robust vascular protective effect of hydroxamic acid derivatives in a sickle mouse model of inflammation. Microcirculation 13 6 (2006) 489-497
15. Zennadi R., Moeller B.J., Whalen E.J., et al. Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo. Blood 110 7 (2007) 2708-2717
16. Kaul D.K., Tsai H.M., Liu X.D., Nakada M.T., Nagel R.L., and Coller B.S. Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor [see comments]. Blood 95 2 (2000) 368-374
17. Kaul D.K., Liu X.D., Zhang X., Mankelow T., Parsons S., Spring F., et al. Peptides based on {alpha}V-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation. Am J Physiol Cell Physiol 291 5 (2006) C922-C930
18. Fabry M.E., Benjamin L., Lawrence C., and Nagel R.L. An objective sign in painful crisis in sickle cell anemia: the concomitant reduction of high-density red cells. Blood 64 2 (1984) 559-563
19. Hebbel R.P. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 100 11 Suppl (1997) S83-S86
20. Hebbel R.P., Boogaerts M.A., Eaton J.W., and Steinberg M.H. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Eng J Med 302 18 (1980) 992-995
21. Hebbel R.P., Eaton J.W., Steinberg M.H., and White J.G. Erythrocyte/endothelial interactions and the vasocclusive severity of sickle cell disease. Prog Clin Biol Res 55 (1981) 145-162
22. Kaul D.K., and Hebbel R.P. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice [see comments]. J Clin Invest 106 3 (2000) 411-420
23. Solovey A., Lin Y., Browne P., Choong S., Wayner E., and Hebbel R.P. Circulating activated endothelial cells in sickle cell anemia [see comments]. N Eng J Med 337 22 (1997) 1584-1590
24. Hebbel R.P., Eaton J.W., Balasingam M., and Steinberg M.H. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 70 6 (1982) 1253-1259
25. Hebbel R.P. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood 77 2 (1991) 214-237
26. Sultana C., Shen Y., Rattan V., Johnson C., and Kalra V.K. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood 92 10 (1998) 3924-3935
27. Villagra J., Shiva S., Hunter L.A., Machado R.F., Gladwin M.T., and Kato G.J. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension and nitric oxide scavenging by cell-free hemoglobin. Blood 110 6 (2007) 2166-2172
28. Kaul D.K., and Fabry M.E. In vivo studies of sickle red blood cells. Microcirculation 11 2 (2004) 153-165
29. Matsui N.M., Varki A., and Embury S.H. Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin. Blood 100 10 (2002) 3790-3796
30. Zennadi R., Hines P.C., De Castro L.M., Cartron J.P., Parise L.V., and Telen M.J. Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions. Blood 104 12 (2004) 3774-3781
31. Manodori A.B., Matsui N.M., Chen J.Y., and Embury S.H. Enhanced adherence of sickle erythrocytes to thrombin-treated endothelial cells involves interendothelial cell gap formation. Blood 92 9 (1998) 3445-3454
32. Wick T.M., Moake J.L., Udden M.M., Eskin S.G., Sears D.A., and McIntire L.V. Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest 80 3 (1987) 905-910
33. Hebbel R.P., Osarogiagbon R., and Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 11 2 (2004) 129-151
34. Barabino G.A., Liu X.D., Ewenstein B.M., and Kaul D.K. Anionic polysaccharides inhibit adhesion of sickle erythrocytes to the vascular endothelium and result in improved hemodynamic behavior. Blood 93 4 (1999) 1422-1429
35. Brittain J.E., Mlinar K.J., Anderson C.S., Orringer E.P., and Parise L.V. Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction. J Clin Invest 107 12 (2001) 1555-1562
36. Hines P.C., Zen Q., Burney S.N., Shea D.A., Ataga K.I., Orringer E.P., et al. Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion. Blood 101 8 (2003) 3281-3287
37. Kaul DK, Tsai HM, Nagel RL, Chen D. Platelet-activating factor enhances adhesion of sickle erythrocytes to vascular endothelium. In: Beuzard Y, Lubin BH, Rosa J, editors. Sickle cell disease and thalassemias: New trends in therapy (INSERM Symposium). Montrouge, France: INSERM/John Libbey Eurotext; 1995 p. 497-500.
38. Setty B.N., Kulkarni S., and Stuart M.J. Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood 99 5 (2002) 1564-1571
39. Reiter C.D., Wang X., Tanus-Santos J.E., et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8 12 (2002) 1383-1389
40. Kaul D.K., Liu X.D., Chang H.Y., Nagel R.L., and Fabry M.E. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice. J Clin Invest 114 8 (2004) 1136-1145
41. Saleh A.W., Duits A.J., Gerbers A., de Vries C., and Hillen H.F. Cytokines and soluble adhesion molecules in sickle cell anemia patients during hydroxyurea therapy. Acta Haematologica 100 1 (1998) 26-31
42. Kaul D.K., Liu X.D., Zhang X., Ma L., Hsia C.J., and Nagel R.L. Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants. Am J Physiol Heart Circ Physiol 291 1 (2006) H167-H175